Professor Michael MacManus is a Radiation Oncologist at Peter Mac specialising in lung cancer and haematological malignancies. He is Associate Director (Research) in the Department of Radiation Oncology at Peter Mac. His research interests include the treatment of lung cancer with radiation therapy and chemoradiation, PET imaging of lung cancer and lymphomas, tumour hypoxia, metastasis and treatment of localised low grade lymphomas. He has published more than 100 journal articles and has more than 3900 citations of his work.
Professor MacManusis an internationally-recognised expert on PET imaging in oncology and has received many invitations to speak on the use of PET for staging, radiation therapy planning and response assessment, especially in lung cancer. He is a Fellow of the International Cancer Imaging Society and has participated in the International Atomic Energy Authority (IAEA) international panel that made recommendations on the use of PET for radiation therapy planning. He is the principal investigator of several clinical trials, including the TROG/ALLLG phase III trial in early stage follicular lymphoma. His recent work includes a collaboration with Associate Professor Olga Martin, leading to the development of a novel method for detecting circulating tumour cells in patient with lung cancer.